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Abstract
Purpose: To investigate the usefulness of Oxygen-Enhanced
Magnetic Resonance Imaging (OE-MRI) changes in signal
intensity related to oxygen challenge for predicting tumor
response to radiation therapy.
Methods: Dynamic MR signal changes were acquired using
Varian 4.7T small animal MR scanner prior to image-guided
radiation therapy (IGRT) of small (n = 6) and large subcuta-
neous (n = 5) prostate tumors in adult male rats. An inter-
leaved blood-oxygen level dependent (BOLD) and tis-
sue-oxygen level dependent (TOLD) data acquisition or (IBT)
was performed using a baseline of medical air as positive
control and using medical oxygen as a breathing challenge.
BOLD used a 2-D multi-slice spoiled gradient-echo with
multi-echo sequence. TOLD used a 2-D multi-slice spoiled
gradient-echo sequence. Voxel changes in signal intensity
were determined by a correlation coefficient mapping tech-
nique. Irradiation technique planned consisted of 1F × 15 Gy
AP/PA or 2F × 7.5 Gy AP/PA to the gross tumor volume
(GTV). Tumor growth measurements were recorded over
time to assess the response to IGRT.
Results: BOLD and TOLD signals variously illustrated posi-
tive or negative impulse responses in the tumor ROI due to
inhaling medical oxygen. Correlation coefficient mapping
demonstrated heterogeneity in tumors after inhaling med-
ical oxygen. BOLD and TOLD signals exhibited increased
changes in signal intensities after the first fraction of dose.
Multi-fractionation had minimum effect until the second
fraction of dose was applied. Tumor growth delays were
observed when inhaling medical oxygen during IGRT.
Conclusion: OE-MRI is a non-invasive imaging modality that
can provide insight to the oxygen status of tumors. Ob-
served increase percent changes in BOLD and TOLD signal
intensities after the first fraction of dose suggest tumors
experienced reoxygenation. OE-MRI could be used for
predicting tumor response to IGRT when using medical ox-
ygen for increasing GTV radiosensitivity, suggesting patient
stratification for clinical implementation.
-----------------------------------------------------------------
Innovation/Impact: Oxygenation in tissue has been
shown to influence MR physical parameters such as the
intrinsic longitudinal relaxation time (T1) and the ap-
parent transverse relaxation time (T2*) 1-5. Investiga-
tions have shown that molecular oxygen when inhaled
and dissolved in tissue fluid or blood plasma, can alter
T1 values in the tissue due to its paramagnetic charac-
teristics 3, 5. Similarly, alterations of T2* values can be
observed in the blood due to the magnetic susceptibil-
ity differences between oxy- and deoxyhemoglobin 3.
Tumor hypoxia is associated with radiation resistance.
However, hitherto there is no satisfactory method to
accurately determine the distribution of partial
pressure of oxygen (pO2) in tumors non-invasively. It
has been suggested that Oxygen-Enhanced MRI
(OE-MRI) may provide insights into tumor hypoxia. I
am exploring a non-invasive imaging technique (Inter-
leaved BOLD/TOLD - IBT) for determining the state of
tumor oxygenation based on changes in signal intensity
from the dependency of BOLD or T2* (blood-oxygen
level dependent) and TOLD or T1 (tissue-oxygen level
dependent) response to a hyperoxic gas challenge prior
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to irradiation, as potential prognostic biomarkers of
response. Indeed, the predictive value may depend on
tumor type and thus it is crucial to evaluate these
methods in diverse tumor types and sites of im-
plantation.
Key Results: For this radiobiological study, experi-
mental tumor models included an adult male nude rat
implanted with 2.5 × 106 PC-3-luc human prostate
cancer cells in the right flank and Dunning R3327-AT1
prostate tumors (typical doubling time approximately 5
days) growing subcutaneously in syngeneic Copenha-
gen rats. The size of experimental tumor models in-
cluded small (1 cc) and large volume tumors (2.5 cc).
For AT1 prostate tumors, tumor growth delay (TGD)
was determined by tumor measurements for up over 40
days or until reached 2 - 4 times the irradiated tumor
volume. For proof-of-principal, the PC-3 prostate TGD
was determined by tumor measurements up to 200
days. Figure 1 and 2 are from a representative large
ATI tumor.
FIG. 1: Tumor Growth
FIG. 2: Dynamic OE-MRI
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